Prevalence and risk factors associated with infections linked to carbapenemase-producing Acinetobacter species circulating in the city of Yaoundé, Cameroon
- PMID: 40761344
- PMCID: PMC12319547
- DOI: 10.1016/j.ijregi.2025.100698
Prevalence and risk factors associated with infections linked to carbapenemase-producing Acinetobacter species circulating in the city of Yaoundé, Cameroon
Abstract
Objectives: Carbapenems are critical antibiotics used against multidrug-resistant infections, yet resistance is increasing, especially among Gram-negative bacteria like Acinetobacter species. In Cameroon, while Acinetobacter baumannii is well studied, little is known about other species such as Acinetobacter pittii, Acinetobacter nosocomialis, and Acinetobacter calcoaceticus. This study assessed the prevalence of carbapenemase-producing Acinetobacter and associated risk factors in Yaoundé hospitals.
Methods: A 6-month prospective cross-sectional study (April-September 2024) was conducted using 531 clinical samples from four health facilities. Strains were identified via morphologic, biochemical, and API 20 NE® tests. Antibiotic susceptibility was assessed using disc diffusion, and carbapenemases were characterized phenotypically.
Results: Of the samples, 4.9% yielded Acinetobacter, with A. baumannii being most common (80.8%), followed by A. calcoaceticus (11.5%) and Acinetobacter anitratus (7.7%). A. baumannii showed high antibiotic resistance, especially to beta-lactams, with 85.71% producing carbapenemases (83.33% class B and 16.67% class A). Significant risk factors included hospitalization, current antibiotic therapy, recent antibiotic use, and age group 38-47 years.
Conclusions: These findings highlight an urgent need for better surveillance, stricter antibiotic stewardship, and enhanced infection control strategies to limit the spread of resistant Acinetobacter infections in Yaoundé's health care settings.
Keywords: Acinetobacter; Carbapenemase; Health facilities; Prevalence; Risk factors; Yaoundé.
© 2025 The Authors.
Conflict of interest statement
The authors have no competing interests to declare.
Figures


Similar articles
-
Performance evaluation of the NG-TEST CARBA 5 and Genobio K.N.I.V.O. detection K-Set lateral flow assays for the detection of carbapenemases.Microbiol Spectr. 2025 Aug 5;13(8):e0044125. doi: 10.1128/spectrum.00441-25. Epub 2025 Jul 18. Microbiol Spectr. 2025. PMID: 40679301 Free PMC article.
-
Distribution of carbapenemase-producing and colistin resistant Acinetobacter baumannii isolates in Batna hospitals, Algeria.BMC Infect Dis. 2025 Jul 1;25(1):825. doi: 10.1186/s12879-025-11198-6. BMC Infect Dis. 2025. PMID: 40596883 Free PMC article.
-
Nationwide surveillance of carbapenem-resistant Gram-negative pathogens in the Lebanese environment.Appl Environ Microbiol. 2025 Jul 23;91(7):e0193224. doi: 10.1128/aem.01932-24. Epub 2025 Jun 10. Appl Environ Microbiol. 2025. PMID: 40492734 Free PMC article.
-
Interventions to improve antibiotic prescribing practices for hospital inpatients.Cochrane Database Syst Rev. 2017 Feb 9;2(2):CD003543. doi: 10.1002/14651858.CD003543.pub4. Cochrane Database Syst Rev. 2017. PMID: 28178770 Free PMC article.
-
A systematic review and meta-analysis for risk factor profiles in patients with resistant Acinetobacter baumannii infection relative to control patients.Int J Risk Saf Med. 2023;34(4):337-355. doi: 10.3233/JRS-220037. Int J Risk Saf Med. 2023. PMID: 37154184
References
LinkOut - more resources
Full Text Sources
Miscellaneous